SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,418,477 | -45.5% | 68,925 | +24.6% | 0.00% | -50.0% |
| Q2 2023 | $2,600,864 | -21.7% | 55,314 | -30.1% | 0.01% | -42.9% |
| Q1 2023 | $3,321,721 | -25.5% | 79,164 | -32.3% | 0.01% | -22.2% |
| Q4 2022 | $4,461,274 | -25.6% | 116,971 | -23.6% | 0.02% | -40.0% |
| Q3 2022 | $5,995,000 | +74.6% | 153,083 | +44.0% | 0.03% | +57.9% |
| Q2 2022 | $3,434,000 | +21.6% | 106,325 | +24.6% | 0.02% | +58.3% |
| Q1 2022 | $2,825,000 | -9.3% | 85,341 | +16.5% | 0.01% | +50.0% |
| Q4 2021 | $3,116,000 | +118.8% | 73,255 | +192.3% | 0.01% | +60.0% |
| Q2 2021 | $1,424,000 | +59.5% | 25,061 | +142.7% | 0.01% | -28.6% |
| Q4 2020 | $893,000 | +64.5% | 10,325 | +16.2% | 0.01% | 0.0% |
| Q3 2020 | $543,000 | -89.3% | 8,882 | -92.7% | 0.01% | -91.5% |
| Q2 2020 | $5,094,000 | +1725.8% | 122,500 | +1160.2% | 0.08% | +1071.4% |
| Q1 2020 | $279,000 | -79.4% | 9,721 | +0.8% | 0.01% | -41.7% |
| Q3 2019 | $1,353,000 | -57.0% | 9,645 | -70.6% | 0.01% | -67.6% |
| Q4 2018 | $3,145,000 | -43.0% | 32,830 | -16.0% | 0.04% | -43.9% |
| Q3 2018 | $5,518,000 | -41.8% | 39,065 | -35.5% | 0.07% | -47.6% |
| Q2 2018 | $9,481,000 | +1224.2% | 60,573 | +1262.7% | 0.13% | +1045.5% |
| Q1 2018 | $716,000 | +188.7% | 4,445 | +11.6% | 0.01% | +120.0% |
| Q3 2017 | $248,000 | -1.6% | 3,982 | +25.9% | 0.01% | 0.0% |
| Q2 2017 | $252,000 | -47.4% | 3,163 | -53.1% | 0.01% | -61.5% |
| Q1 2017 | $479,000 | +48.8% | 6,746 | +7.1% | 0.01% | 0.0% |
| Q4 2016 | $322,000 | -34.0% | 6,300 | -61.1% | 0.01% | -56.7% |
| Q2 2016 | $488,000 | +139.2% | 16,200 | +362.9% | 0.03% | +36.4% |
| Q4 2015 | $204,000 | +0.5% | 3,500 | -27.1% | 0.02% | -56.9% |
| Q3 2015 | $203,000 | – | 4,800 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |